This research seeks to systematically examine the association between ALDOC-mediated aerobic glycolysis and NB pathogenesis, while further evaluating its potential impact on the therapeutic efficacy of conventional chemotherapeutic agents (cisplatin and cyclophosphamide) in NB treatment. Here, ALDOC is linked to neuroblastoma.